Search

everythinglearnresearchcommunity

for

Search:↓

Partial hair-sparing brain radiotherapy is possible and doesn't affect cancer control but still causes noticeable hair loss.

Permanent hair loss after bone marrow transplant can be caused by chemotherapy or chronic graft-versus-host disease.

A patient with Cronkhite-Canada Syndrome developed colon cancer that spread to the liver, showing the need for regular cancer checks in such patients.

Treatment strategies for breast cancer affect blood health, causing issues like anemia and require nutritional counseling.

Ovarian steroid cell tumors should be considered in adults with hirsutism and high testosterone, with surgery as the main treatment.

Horticultural therapy helped cancer patients feel hopeful and positive about their disease experience.

More research is needed to understand chemotherapy-induced hair loss and its phases.

Food-derived peptides may help prevent diseases like high blood pressure and high cholesterol, and can support the immune system.

A pancreatic tumor caused high glucagon levels and symptoms, but treatment reduced glucagon and shrank liver tumors.

Chronic hair diseases can severely affect mental health and self-confidence.

Hair loss can be caused by stress, infections, drugs, and various diseases, with treatment depending on accurate diagnosis.

A woman with Cushing's syndrome improved after surgery to remove a tumor causing the condition.

The patient's long-term hair loss was caused by leukemia treatments and low estrogen levels, worsened by her genetic tendency for hair loss.

Mindfulness intervention greatly improves quality of life and reduces distress in women with breast cancer.

Permanent hair loss after a stem cell transplant can be a sign of chronic immune system attack on the scalp.

Bexxar is highly effective as a first treatment for non-Hodgkin's lymphoma, with most patients alive and many in remission after eight years.

Rare skin cancer can mimic hair loss conditions, so thorough diagnosis is crucial.

Taxane-based chemotherapy causes more hair loss and skin changes in Asian breast cancer patients.

Phenytoin and spironolactone help prevent hair loss from chemotherapy by reducing stress and inflammation.

Trichilemmal carcinoma is rare, usually benign after removal, but needs close follow-up due to recurrence risks.

A man's rare adrenal tumor caused feminization and white hair, was removed surgically, and improved after treatment.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Chemotherapy causes temporary hair loss in women, while Tamoxifen does not significantly affect hair, and genetics show no link between female pattern hair loss and common baldness genes.

Breast cancer survivors often face body image and sexual health issues, needing ongoing support and open communication with healthcare providers.

Genetic testing for cancer risk can lead to early and life-saving treatments in people without symptoms.

Chronic hair diseases can severely impact mental health and self-confidence.

Early baldness in men may indicate risks for obesity, metabolic syndrome, insulin resistance, and heart disease, similar to women with PCOS. Alopecia areata is often linked with autoimmune diseases and mental health issues. Certain hair disorders are due to genetic issues, and chemotherapy can cause hair loss through specific biological pathways. Iron deficiency's link to hair loss is still disputed.

Bortezomib chemotherapy can cause temporary skin rashes.

Multiphoton microscopy can effectively assess breast cancer treatment responses without labels.

Breast cancer survivors may have a higher risk of falls, tamoxifen could prevent breast cancer and deaths, new guidelines urge caution with prostate cancer therapy, and early balding in men may indicate a higher prostate cancer risk.